Sickle cell disease: renal manifestations and mechanisms
about
2015 Clinical trials update in sickle cell anemiaTreating sickle cell disease by targeting HbS polymerizationUrinary Bladder Dysfunction in Transgenic Sickle Cell Disease MiceRole of innate immunity-triggered pathways in the pathogenesis of Sickle Cell Disease: a meta-analysis of gene expression studiesPhase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell DiseaseChanges in Conjunctival Hemodynamics Predict Albuminuria in Sickle Cell Nephropathy.Endothelin-1 and the kidney: new perspectives and recent findings.Plasma heme-induced renal toxicity is related to a capillary rarefaction.Sickle Cell Trait and Renal Function in Hispanics in the United States: The Northern Manhattan Study.Interventions for chronic kidney disease in people with sickle cell disease.Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.Therapeutic potential of endothelin receptor antagonism in kidney disease.Interventions for chronic kidney disease in people with sickle cell disease.Hemoglobin inhibits albumin uptake by proximal tubule cells: implications for sickle cell disease.Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach.Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.Patterns of opioid use in sickle cell disease.Reversible kidney iron accumulation in a patient with sickle cell disease treated with hydroxyurea.Medullary Microvascular Thrombosis and Injury in Sickle Hemoglobin C Disease.Prevalence and determinants of microalbuminuria in children suffering from sickle cell anemia in steady stateSickle cell disease and albuminuria: recent advances in our understanding of sickle cell nephropathy.Increased prevalence of renal cysts in patients with sickle cell disease.Increased vancomycin dosing requirements in sickle cell disease due to hyperfiltration-dependent and independent pathways.Undetectable haptoglobin is associated with major adverse kidney events in critically ill burn patients.The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait.Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion.Posterior reversible encephalopathy syndrome secondary to asymptomatic poststreptococcal glomerulonephritis in a child with sickle cell anemia: a case report.Nutcracker Syndrome and Sickle Cell Trait: A Perfect Storm for Hematuria.Normal saline is associated with increased sickle red cell stiffness and prolonged transit times in a microfluidic model of the capillary system.Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice.Improved Fetal Hemoglobin With mTOR Inhibitor-Based Immunosuppression in a Kidney Transplant Recipient With Sickle Cell Disease.RON kinase inhibition reduces renal endothelial injury in sickle cell disease mice.Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models.Endothelin-A Receptor Antagonism Retards the Progression of Murine Sickle Cell Nephropathy.Acute kidney injury in children with sickle cell disease-compounding a chronic problem.Kidney Transplantation From a Donor With Sickle Cell Disease.Nontraumatic Exertional Rhabdomyolysis Leading to Acute Kidney Injury in a Sickle Trait Positive Individual on Renal Biopsy.Sickle cell disease: a natural model of acute and chronic pain.Sickle Cell Disease Clinical Trials and Phenotypes
P2860
Q28086979-8F336158-1A2D-4E3D-86C9-B1076E55BC69Q33707352-B2E06677-BCC3-4EF8-85ED-945DE4CE25E4Q35737367-7B9B9923-84FB-4135-B2C3-C3A9DD426ED0Q35863787-A208D811-12B2-49CE-BF24-9450FD654AF6Q35987429-45418C4D-5476-4CCC-AA74-DC3B993E55E5Q36030994-6CA72099-22C2-44AA-904B-3A35B1327644Q36421114-65CD1BA3-E85A-43AD-B7C0-5FF37DE99CD2Q37576060-D9BC8FFE-5C67-4DE4-ABA2-C6F94FCADC48Q37594335-01409EB0-0AD8-477B-9283-C5B8C5D76869Q37713880-4D54F720-DEEE-4E0F-AC84-23C560E3CBC3Q38627797-F4ABDF46-477D-4E2A-B3C9-1023F628CA4AQ38678678-89E2AD07-9182-40C7-86B6-B3EF81883C92Q38696578-2E7DAA21-22C9-43C2-881E-7D6C4E079C43Q38709717-A5F09B46-7B6C-42B9-B94B-15784B802B14Q38799393-92D85541-A25A-4D8B-8384-F5D24B94219FQ39378958-68F7CC4E-60B0-4570-84AC-85022B67A983Q39551420-C6FDAE98-5C3F-4250-B366-8A6A475BB458Q40603878-3DA55C87-7E3A-4197-93AB-AD464A3E1355Q40775991-69E3AC74-CB80-4B7C-9427-08D1BAF2BBA8Q41509966-D56FA8B2-D27F-462F-80A4-BA6DCBFDE74CQ41510616-AA7FEE1B-BFD3-413E-A68B-2FBF4653515EQ41691127-0652B7E7-BEE1-46BD-8219-8009EAB54B2DQ42341701-7D3F9378-479A-417A-9AAD-F7A84DB6A4B9Q42363885-A7F97DDE-75EA-4FAF-84FE-9EBBF2F3AC6FQ47129770-BE5ED7DE-0993-45B4-AF0C-0F2D1B2D0B9EQ47189835-9D80DA76-1D96-4D1F-96FC-84E0A0C14426Q47600946-A3E752DE-D979-4293-B6FA-CD5EA96199ABQ47828510-9CE90245-BA25-4366-9185-6D4E0AD160FCQ47966930-87EE22D5-BCC9-4A7D-BDFF-66533FA6206EQ48049333-FD749D25-423C-42CB-BEE8-3BBEB6DA7E3EQ50667811-70ADD32A-EB1A-46A8-A2B9-82A31FEDCA13Q51836741-C1867C7B-0E5E-40BD-8D7F-ED44B3C2CD22Q52665808-5F20172A-72A2-4691-A74F-E7BAC4F29FC1Q52730639-F1AA18C8-D1CE-4560-8BBB-433022756C2DQ52775082-49FBB304-BD5F-4D68-A2B5-90C3BF1552DFQ52779255-35D197D2-1210-488A-9397-1A8D71FD3DC7Q52842165-A3390421-C8A7-472B-A5CA-47AF37A7F8A0Q55006118-324CC55A-E3CC-4077-AC40-3E2B95420977Q55053106-1D2EABBE-87AC-4788-A8AF-B63C12081142Q58581652-563F28A3-73C9-448D-BABC-8F539E9293A9
P2860
Sickle cell disease: renal manifestations and mechanisms
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Sickle cell disease: renal manifestations and mechanisms
@en
type
label
Sickle cell disease: renal manifestations and mechanisms
@en
prefLabel
Sickle cell disease: renal manifestations and mechanisms
@en
P2860
P356
P1476
Sickle cell disease: renal manifestations and mechanisms
@en
P2093
Karl A Nath
Robert P Hebbel
P2860
P2888
P304
P356
10.1038/NRNEPH.2015.8
P407
P577
2015-02-10T00:00:00Z